{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:18:09Z","timestamp":1790774289412,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T00:00:00Z","timestamp":1444003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/onc.2015.363","type":"journal-article","created":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T10:04:27Z","timestamp":1444039467000},"page":"3004-3015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer"],"prefix":"10.1038","volume":"35","author":[{"given":"S-J","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Snell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Turley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-L","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M W","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Heublein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A L","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D C I","family":"Goberdhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,5]]},"reference":[{"key":"BFonc2015363_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nature11706","volume":"491","author":"A Schulze","year":"2012","unstructured":"Schulze A, Harris AL . How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 2012; 491: 364\u2013373.","journal-title":"Nature"},{"key":"BFonc2015363_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.tcb.2014.03.003","volume":"24","author":"L Bar-Peled","year":"2014","unstructured":"Bar-Peled L, Sabatini DM . Regulation of mTORC1 by amino acids. Trends Cell Biol 2014; 24: 400\u2013406.","journal-title":"Trends Cell Biol"},{"key":"BFonc2015363_CR3","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bbapap.2012.12.010","volume":"1834","author":"AR Malik","year":"2012","unstructured":"Malik AR, Urbanska M, Macias M, Skalecka A, Jaworski J . Beyond control of protein translation: What we have learned about the non-canonical regulation and function of mammalian target of rapamycin (mTOR). Biochim Biophys Acta 2012; 1834: 1434\u20131448.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc2015363_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.tibs.2013.01.004","volume":"38","author":"JL Jewell","year":"2013","unstructured":"Jewell JL, Guan KL . Nutrient signaling to mTOR and cell growth. Trends Biochem Sci 2013; 38: 233\u2013242.","journal-title":"Trends Biochem Sci"},{"key":"BFonc2015363_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2012.01.005","volume":"319","author":"YY Zaytseva","year":"2012","unstructured":"Zaytseva YY, Valentino JD, Gulhati P, Evers BM . mTOR inhibitors in cancer therapy. Cancer Lett 2012; 319: 1\u20137.","journal-title":"Cancer Lett"},{"key":"BFonc2015363_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4161\/cc.11.3.19096","volume":"11","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Zheng XF . mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors. Cell Cycle 2012; 11: 594\u2013603.","journal-title":"Cell Cycle"},{"key":"BFonc2015363_CR7","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1158\/1078-0432.CCR-10-0433","volume":"16","author":"AC Hsieh","year":"2010","unstructured":"Hsieh AC, Ruggero D . Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer. Clin Cancer Res 2010; 16: 4914\u20134920.","journal-title":"Clin Cancer Res"},{"key":"BFonc2015363_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature10912","volume":"485","author":"AC Hsieh","year":"2012","unstructured":"Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 2012; 485: 55\u201361.","journal-title":"Nature"},{"key":"BFonc2015363_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature11083","volume":"485","author":"CC Thoreen","year":"2012","unstructured":"Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM . A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012; 485: 109\u2013113.","journal-title":"Nature"},{"key":"BFonc2015363_CR10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1158\/2159-8290.CD-13-0929","volume":"4","author":"BC Grabiner","year":"2014","unstructured":"Grabiner BC, Nardi V, Birsoy K, Possemato R, Shen K, Sinha S et al. A diverse array of cancer-associated mTOR mutations are hyperactivating and can predict rapamycin sensitivity. Cancer Discov 2014; 4: 554\u2013563.","journal-title":"Cancer Discov"},{"key":"BFonc2015363_CR11","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1111\/j.1476-5381.2011.01438.x","volume":"164","author":"DT Thwaites","year":"2011","unstructured":"Thwaites DT, Anderson CM . The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport. Br J Pharmacol 2011; 164: 1802\u20131816.","journal-title":"Br J Pharmacol"},{"key":"BFonc2015363_CR12","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1242\/dev.01821","volume":"132","author":"DC Goberdhan","year":"2005","unstructured":"Goberdhan DC, Meredith D, Boyd CA, Wilson C . PAT-related amino acid transporters regulate growth via a novel mechanism that does not require bulk transport of amino acids. Development 2005; 132: 2365\u20132375.","journal-title":"Development"},{"key":"BFonc2015363_CR13","doi-asserted-by":"publisher","first-page":"e36616","DOI":"10.1371\/journal.pone.0036616","volume":"7","author":"MH Ogmundsdottir","year":"2012","unstructured":"Ogmundsdottir MH, Heublein S, Kazi S, Reynolds B, Visvalingam SM, Shaw MK et al. Proton-assisted amino acid transporter PAT1 complexes with Rag GTPases and activates TORC1 on late endosomal and lysosomal membranes. PLoS One 2012; 7: e36616.","journal-title":"PLoS One"},{"key":"BFonc2015363_CR14","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1038\/onc.2010.177","volume":"29","author":"S Heublein","year":"2010","unstructured":"Heublein S, Kazi S, Ogmundsdottir MH, Attwood EV, Kala S, Boyd CA et al. Proton-assisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation. Oncogene 2010; 29: 4068\u20134079.","journal-title":"Oncogene"},{"key":"BFonc2015363_CR15","doi-asserted-by":"publisher","first-page":"7206","DOI":"10.1073\/pnas.121183498","volume":"98","author":"C Sagne","year":"2001","unstructured":"Sagne C, Agulhon C, Ravassard P, Darmon M, Hamon M, El Mestikawy S et al. Identification and characterization of a lysosomal transporter for small neutral amino acids. Proc Natl Acad Sci USA 2001; 98: 7206\u20137211.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2015363_CR16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1523\/JNEUROSCI.23-04-01265.2003","volume":"23","author":"CC Wreden","year":"2003","unstructured":"Wreden CC, Johnson J, Tran C, Seal RP, Copenhagen DR, Reimer RJ et al. The H+-coupled electrogenic lysosomal amino acid transporter LYAAT1 localizes to the axon and plasma membrane of hippocampal neurons. J Neurosci 2003; 23: 1265\u20131275.","journal-title":"J Neurosci"},{"key":"BFonc2015363_CR17","first-page":"1360","volume":"11","author":"DC Goberdhan","year":"2010","unstructured":"Goberdhan DC . Intracellular amino acid sensing and mTORC1-regulated growth: new ways to block an old target? Curr Opin Invest Drugs 2010; 11: 1360\u20131367.","journal-title":"Curr Opin Invest Drugs"},{"key":"BFonc2015363_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1126\/science.1257132","volume":"347","author":"S Wang","year":"2015","unstructured":"Wang S, Tsun ZY, Wolfson RL, Shen K, Wyant GA, Plovanich ME et al. Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science 2015; 347: 188\u2013194.","journal-title":"Science"},{"key":"BFonc2015363_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature14107","volume":"19","author":"M Rebsamen","year":"2015","unstructured":"Rebsamen M, Pochini L, Stasyk T, de Ara\u00fajo ME, Galluccio M, Kandasamy RK et al. SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1. Nature 2015; 19: 477\u2013481.","journal-title":"Nature"},{"key":"BFonc2015363_CR20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ccell.2014.09.008","volume":"26","author":"JD Thomas","year":"2014","unstructured":"Thomas JD, Zhang YJ, Wei YH, Cho JH, Morris LE, Wang HY et al. Rab1A is an mTORC1 activator and a colorectal oncogene. Cancer Cell 2014; 26: 754\u2013769.","journal-title":"Cancer Cell"},{"key":"BFonc2015363_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1126\/science.1259472","volume":"347","author":"JL Jewell","year":"2015","unstructured":"Jewell JL, Kim YC, Russell RC, Yu FX, Park HW, Plouffe SW et al. Metabolism. Differential regulation of mTORC1 by leucine and glutamine. Science 2015; 347: 194\u2013198.","journal-title":"Science"},{"key":"BFonc2015363_CR22","doi-asserted-by":"publisher","first-page":"25477","DOI":"10.1074\/jbc.M111.249631","volume":"286","author":"L Xu","year":"2011","unstructured":"Xu L, Salloum D, Medlin PS, Saqcena M, Yellen P, Perrella B et al. Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1). J Biol Chem 2011; 286: 25477\u201325486.","journal-title":"J Biol Chem"},{"key":"BFonc2015363_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1083\/jcb.201107033","volume":"195","author":"MS Yoon","year":"2011","unstructured":"Yoon MS, Du G, Backer JM, Frohman MA, Chen J . Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway. J Cell Biol 2011; 195: 435\u2013447.","journal-title":"J Cell Biol"},{"key":"BFonc2015363_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3322\/caac.21220","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Desantis C, Jemal A . Colorectal cancer statistics, 2014. CA Cancer J Clin 2014; 64: 104\u2013117.","journal-title":"CA Cancer J Clin"},{"key":"BFonc2015363_CR25","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1517\/13543784.2012.721353","volume":"21","author":"DD Kim","year":"2012","unstructured":"Kim DD, Eng C . The promise of mTOR inhibitors in the treatment of colorectal cancer. Expert Opin Invest Drugs 2012; 21: 1775\u20131788.","journal-title":"Expert Opin Invest Drugs"},{"key":"BFonc2015363_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nature11776","volume":"493","author":"P Jiang","year":"2013","unstructured":"Jiang P, Du W, Mancuso A, Wellen KE, Yang X . Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 2013; 493: 689\u2013693.","journal-title":"Nature"},{"key":"BFonc2015363_CR27","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature11743","volume":"493","author":"OD Maddocks","year":"2013","unstructured":"Maddocks OD, Berkers CR, Mason SM, Zheng L, Blyth K, Gottlieb E et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 2013; 493: 542\u2013546.","journal-title":"Nature"},{"key":"BFonc2015363_CR28","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1038\/sj.onc.1208648","volume":"24","author":"C Constantinou","year":"2005","unstructured":"Constantinou C, Clemens MJ . Regulation of the phosphorylation and integrity of protein synthesis initiation factor eIF4GI and the translational repressor 4E-BP1 by p53. Oncogene 2005; 24: 4839\u20134850.","journal-title":"Oncogene"},{"key":"BFonc2015363_CR29","doi-asserted-by":"publisher","first-page":"20750","DOI":"10.1074\/jbc.M011068200","volume":"276","author":"MM Karim","year":"2001","unstructured":"Karim MM, Hughes JM, Warwicker J, Scheper GC, Proud CG, McCarthy JE . A quantitative molecular model for modulation of mammalian translation by the eIF4E-binding protein 1. J Biol Chem 2001; 276: 20750\u201320757.","journal-title":"J Biol Chem"},{"key":"BFonc2015363_CR30","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/onc.2013.92","volume":"33","author":"GS Ducker","year":"2014","unstructured":"Ducker GS, Atreya CE, Simko JP, Hom YK, Matli MR, Benes CH et al. Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors. Oncogene 2014; 33: 1590\u20131600.","journal-title":"Oncogene"},{"key":"BFonc2015363_CR31","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1038\/cddis.2013.60","volume":"4","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Butler EB, Tan M . Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis 2013; 4: e532.","journal-title":"Cell Death Dis"},{"key":"BFonc2015363_CR32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.1207056","volume":"334","author":"R Zoncu","year":"2011","unstructured":"Zoncu R, Bar-Peled L, Efeyan A, Wang S, Sancak Y, Sabatini DM . mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 2011; 334: 678\u2013683.","journal-title":"Science"},{"key":"BFonc2015363_CR33","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/nmeth947","volume":"3","author":"O S\u00f6derberg","year":"2006","unstructured":"S\u00f6derberg O, Gullberg M, Jarvius M, Ridderstr\u00e4le K, Leuchowius K-J, Jarvius J et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 2006; 3: 995\u20131000.","journal-title":"Nat Methods"},{"key":"BFonc2015363_CR34","doi-asserted-by":"publisher","first-page":"1236566","DOI":"10.1126\/science.1236566","volume":"341","author":"SA Kang","year":"2013","unstructured":"Kang SA, Pacold ME, Cervantes CL, Lim D, Lou HJ, Ottina K et al. mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin. Science 2013; 341: 1236566.","journal-title":"Science"},{"key":"BFonc2015363_CR35","doi-asserted-by":"publisher","first-page":"19705","DOI":"10.1074\/jbc.C110.102483","volume":"285","author":"L Li","year":"2010","unstructured":"Li L, Kim E, Yuan H, Inoki K, Goraksha-Hicks P, Schiesher RL et al. Regulation of mTORC1 by the Rab and Arf GTPases. J Biol Chem 2010; 285: 19705\u201319709.","journal-title":"J Biol Chem"},{"key":"BFonc2015363_CR36","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/embor.2013.32","volume":"14","author":"T Matsui","year":"2013","unstructured":"Matsui T, Fukuda M . Rab12 regulates mTORC1 activity and autophagy through controlling the degradation of amino-acid transporter PAT4. EMBO Rep 2013; 14: 450\u2013457.","journal-title":"EMBO Rep"},{"key":"BFonc2015363_CR37","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1074\/jbc.M110.172403","volume":"286","author":"SM Pillai","year":"2011","unstructured":"Pillai SM, Meredith D . SLC36A4 (hPAT4) is a high affinity amino acid transporter when expressed in Xenopus laevis oocytes. J Biol Chem 2011; 286: 2455\u20132460.","journal-title":"J Biol Chem"},{"key":"BFonc2015363_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009; 136: 521\u2013534.","journal-title":"Cell"},{"key":"BFonc2015363_CR39","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1158\/0008-5472.CAN-11-1704","volume":"71","author":"JL Li","year":"2011","unstructured":"Li JL, Sainson RC, Oon CE, Turley H, Leek R, Sheldon H et al. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo. Cancer Res 2011; 71: 6073\u20136083.","journal-title":"Cancer Res"},{"key":"BFonc2015363_CR40","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","volume":"141","author":"Y Sancak","year":"2010","unstructured":"Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM . Ragulator\u2013Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010; 141: 290\u2013303.","journal-title":"Cell"},{"key":"BFonc2015363_CR41","doi-asserted-by":"publisher","first-page":"11244","DOI":"10.1158\/0008-5472.CAN-07-0969","volume":"67","author":"JL Li","year":"2007","unstructured":"Li JL, Sainson RC, Shi W, Leek R, Harrington LS, Preusser M et al. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res 2007; 67: 11244\u201311253.","journal-title":"Cancer Res"},{"key":"BFonc2015363_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/path.893","volume":"195","author":"L Bubendorf","year":"2001","unstructured":"Bubendorf L, Nocito A, Moch H, Sauter G . Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001; 195: 72\u201379.","journal-title":"J Pathol"},{"key":"BFonc2015363_CR43","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1073\/pnas.0813167106","volume":"106","author":"A Rath","year":"2009","unstructured":"Rath A, Glibowicka M, Nadeau VG, Chen G, Deber CM . Detergent binding explains anomalous SDS\u2013PAGE migration of membrane proteins. Proc Natl Acad Sci USA 2009; 106: 1760\u20131765.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/onc2015363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2015363","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2015363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:58:41Z","timestamp":1684472321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2015363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,5]]},"references-count":43,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["BFonc2015363"],"URL":"https:\/\/doi.org\/10.1038\/onc.2015.363","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,5]]},"assertion":[{"value":"30 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}